Michael Scolaro

Michael Scolaro

Sep 18, 2017

Group 6 Copy 95
0
    Please wait...

    About This Project

    We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Antibiotics and Affect: Avenues for Addiction Management

    Addictions to cocaine and other stimulant 'designer' drugs remain unaided by pharmacotherapies. Several...

    Developing a new treatment for Ebola Virus Disease

    Ebola is now a threat of global significance. Fatalities are a consequence of the human body's overreactive...

    Backer Badge Funded